Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-031720
Filing Date
2025-10-24
Accepted
2025-10-24 16:03:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A aytu20251017_defa14a.htm DEFA14A 10706
2 notice01.jpg GRAPHIC 501024
3 notice02.jpg GRAPHIC 504360
  Complete submission text file 0001437749-25-031720.txt   1396700
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 251416158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)